 |
ReNeuron
Last updated: October 10, 2024
CEO Olav Hellebo
UK | Funding: $166.4M (+)
Website: http://www.reneuron.com/
We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
Website: http://www.reneuron.com/
We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
